SAATH is a ‘One AXA’ public health initiative between AXA France Vie, AXA GO Business Operations, and AXA XL
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
Alongside brand refresh, the leading clinical trial technology company announces eConsent and eCOA offerings to better support the patient clinical trial journey
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
Covaxin is not approved in the USA for any age group
Subscribe To Our Newsletter & Stay Updated
